Clinical Trial: Spermotrend in the Treatment of Male Infertility
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Assessment of the Efficacy of Dietary Supplement Spermotrend in the Treatment of Male Infertility
Brief Summary: The purpose of this study is to determine whether the administration of the dietary supplement Spermotrend improves spermatogenesis parameters in subjects with male infertility unrelated to major testicular conditions. The duration of this double-blind placebo controlled phase 3 clinical trial will be 24 weeks. The estimated number of males with infertility to be recruited and randomized for the study is 86.
Detailed Summary:
Sponsor: Catalysis SL
Current Primary Outcome: Parameters of seminal analysis at weeks 24 [ Time Frame: 24 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Fertilization achievement [ Time Frame: 24 weeks ]
- Presence of mild or severe adverse effects [ Time Frame: 24 weeks ]
Original Secondary Outcome: Same as current
Information By: Catalysis SL
Dates:
Date Received: September 10, 2009
Date Started: September 2009
Date Completion:
Last Updated: March 6, 2011
Last Verified: March 2011
